Company | Ticker | Business Description | Underwriters | Offer Date |
---|---|---|---|---|
Azitra> | AZTR> | Phase 1-ready dermatology biotech developing engineered bacterial therapies. | ThinkEquity |
06/15/23 |
Biofrontera> | BFRI> | Spinoff of Biofrontera AG's commercialized dermatology portfolio. | Roth Cap. The Benchmark Compan |
10/28/21 |
Dermata Therapeutics> | DRMA> | Phase 3-ready biotech developing therapies for skin conditions using freshwater sponge. | Maxim Brookline Cap.Mkts |
08/12/21 |
Dermavant Sciences> | DRMT> | Phase 3 biotech developing in-licensed therapies for dermatological diseases. | Jefferies Leerink Partners |
Withdrawn |
Journey Medical> | DERM> | Owns a portfolio of acquired drugs marketed for skin conditions. | B. Riley Sec. Roth Cap. |
11/11/21 |
Oneness Biotech> | |